LUFAX Holding shows an operational inflection point, J.P. Morgan upgrades to Overweight

Overview

This report focuses on the fundamental inflection point following LUFAX Holding’s 2Q26 operational update. J.P. Morgan believes that new loan origination has resumed positive growth, contraction in outstanding loan balance has moderated, leading asset quality indicators have improved, and valuation remains at distressed levels, with the current share price not yet fully reflecting the operational recovery and optionality from cash assets.

Core views

The core views include three points: first, leading indicators of both loan scale and asset quality suggest fundamentals are bottoming out and improving; second, the company’s loan IRR is below peers, giving it relative resilience under a potential 4×LPR cap or broader loan pricing regulation; third, the 1H26 interim results in August may improve earnings visibility, and any dividends, buybacks, or clearer capital management commitments could provide additional re-rating catalysts.

Analysis framework

The report evaluates LUFAX Holding’s risk-reward by combining 2Q26 operating data, loan growth, outstanding loan balance, C-M3, D30, D90, NPL ratio, risk retention ratio, loan IRR, comparison of cash and market capitalization, and a P/B-ROE valuation model.

Methodology notes

• Valuation methodsP/B-ROE model

  Price-to-book and return-on-equity valuation

  The Dec-27 target price of US$2.00 is based on a P/B-ROE model, assuming a cost of equity of 19.8%, normalized ROE of 7.6%, and a terminal date of December 31, 2028.

• operating_analysisloan growth and asset quality indicators

  Leading indicators of loan growth and asset quality

  Operational recovery and the inflection point in credit costs are assessed through new loan origination, outstanding loan balance, C-M3, D30, D90, and the consumer finance NPL ratio.

• regulatory_analysisloan IRR cap sensitivity

  Sensitivity to loan pricing regulation

  LUFAX’s IRR on new loans is compared with peers to assess margin pressure if interest rate caps or regulation on loan facilitation fees tightens further.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• LU.US

  primary_coverage

  Strengths

  Recovery in loan growth, improvement in leading asset quality indicators, regulatory resilience from low IRR, bottom-of-cycle valuation, and ample cash assets.

  Weaknesses

  Short-term ROE remains low, lagging delinquency indicators such as D90 are still elevated, and management changes add governance uncertainty.

  Comparison

  Compared with higher-IRR peers, LUFAX faces less pricing and margin pressure under potentially tighter loan pricing regulation.

  Risks

  Further regulatory tightening, higher-than-expected impairment costs, intensifying competition in online loan facilitation, and unfavorable developments in securities fraud litigation.

• QFIN

  peer_read_across

  Strengths

  Improvement in LUFAX’s C-M3 and D30 and the recovery in loan growth provide a positive read-across for QFIN’s asset quality improvement and loan growth recovery.

  Weaknesses

  Lagging industry indicators such as D90 may still remain elevated, and the pace of recovery still needs to be validated by subsequent data.

  Comparison

  The report views LUFAX’s operational update as a signal of stabilizing credit conditions in the online lending platform industry.

  Risks

  If regulation tightens or industry credit cost improvement is slower than expected, peer valuation and earnings recovery could come under pressure.

Key data

• 2Q26 new loan originationRmb51.1bnUp 4.6% year over year and 5% quarter over quarter.
• 2Q26 outstanding loan balanceRmb167.3bnDown 3% quarter over quarter, with the contraction moderating from the 6% quarter-over-quarter decline in 1Q26.
• C-M31.0%Down 20 bps quarter over quarter in 2Q26.
• D305.8%Down 30 bps quarter over quarter in 2Q26.
• D903.7%Up 30 bps quarter over quarter in 2Q26, with lagging delinquency indicators still elevated.
• Consumer finance NPL ratio1.3%Down from 1.4% at the end of 1Q26.
• 2025 blended IRR on new loans18.6%Below the peer average of about 21.8%; consumer finance loan IRR was 17.2%.
• Forward P/B0.1xNear historical lows.
• Market cap / ending cash37%Market capitalization is about 37% of FY25 ending cash.
• Target priceUS$2.00Implies 45% upside versus the current price of US$1.38.

Impact & implications

The report’s conclusion is positive on LUFAX Holding: if the 2Q26 operational improvement is validated in the 1H26 income statement, the market may reassess its distressed valuation; meanwhile, cash reserves and potential shareholder returns provide additional optionality for valuation recovery. There is also a positive read-across to peer QFIN, as LUFAX’s improving asset quality and loan growth may indicate a stabilizing credit environment for the industry.

Risks

• Further regulatory tightening, especially if the 4×LPR cap extends from small loans to other loan types.
• Impairment costs under the full-guarantee model may be higher than expected.
• Competition among online loan facilitation platforms may intensify.
• Unfavorable developments in securities fraud litigation or settlement amounts higher than expected.
• The departure of the CFO and several non-executive directors creates uncertainty around governance and internal control reset.
• The D90 delinquency ratio is still rising, and there may be a lag before improvement in leading indicators translates into lower credit costs.

What to watch

• Whether the 1H26 interim results to be released in August can validate earnings recovery.
• Whether new loan origination growth can continue to remain positive.
• Whether improvement in C-M3 and D30 will transmit to lower D90 and credit costs.
• Whether dividends, buybacks, or clearer capital management commitments emerge.
• Whether loan pricing regulation tightens further or expands in scope.
• Appointment of a permanent CFO, board stability, and progress in HKEX-related internal control review.